Charles Schwab Investment Management Inc Abiomed Inc Transaction History

Charles Schwab Investment Management Inc

$515 Billion
Q3 2024

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	BUY	$242.49 - $301.46 $1.6 Million - $1.99 Million	6,585 Added 1.8%	372,287 $91.5 Million
Q2 2022 Aug 15, 2022	BUY	$224.73 - $338.64 $2.45 Million - $3.69 Million	10,885 Added 3.07%	365,702 $90.5 Million
Q1 2022 May 13, 2022	BUY	$277.25 - $366.29 $2.99 Million - $3.96 Million	10,802 Added 3.14%	354,817 $118 Million
Q4 2021 Feb 11, 2022	BUY	$300.63 - $371.35 $3.19 Million - $3.94 Million	10,623 Added 3.19%	344,015 $124 Million
Q3 2021 Nov 16, 2021	BUY	$310.19 - $376.2 $3.72 Million - $4.51 Million	11,986 Added 3.73%	333,392 $109 Million
Q2 2021 Aug 16, 2021	BUY	$262.71 - $351.17 $2.29 Million - $3.06 Million	8,720 Added 2.79%	321,406 $100 Million
Q1 2021 May 17, 2021	SELL	$285.92 - $355.13 $16.5 Million - $20.5 Million	-57,800 Reduced 15.6%	312,686 $99.7 Million
Q4 2020 Feb 16, 2021	BUY	$251.88 - $324.2 $720,628 - $927,536	2,861 Added 0.78%	370,486 $120 Million
Q3 2020 Nov 13, 2020	SELL	$255.22 - $317.0 $2.9 Million - $3.61 Million	-11,380 Reduced 3.0%	367,625 $102 Million
Q2 2020 Aug 14, 2020	SELL	$141.4 - $257.09 $1.66 Million - $3.03 Million	-11,767 Reduced 3.01%	379,005 $91.6 Million
Q1 2020 May 15, 2020	BUY	$130.51 - $196.01 $4.76 Million - $7.14 Million	36,446 Added 10.29%	390,772 $56.7 Million
Q4 2019 Feb 07, 2020	BUY	$159.31 - $223.54 $10.5 Million - $14.8 Million	66,160 Added 22.96%	354,326 $60.4 Million
Q3 2019 Nov 08, 2019	BUY	$175.89 - $279.23 $18.1 Million - $28.8 Million	103,028 Added 55.65%	288,166 $51.3 Million
Q2 2019 Aug 09, 2019	BUY	$250.96 - $284.94 $2.06 Million - $2.34 Million	8,225 Added 4.65%	185,138 $48.2 Million
Q1 2019 May 14, 2019	BUY	$276.39 - $362.25 $2.04 Million - $2.68 Million	7,395 Added 4.36%	176,913 $50.5 Million
Q4 2018 Feb 14, 2019	BUY	$281.08 - $444.25 $1.7 Million - $2.69 Million	6,049 Added 3.7%	169,518 $55.1 Million
Q3 2018 Nov 13, 2018	SELL	$354.53 - $449.75 $18.7 Million - $23.7 Million	-52,612 Reduced 24.35%	163,469 $73.5 Million
Q2 2018 Aug 08, 2018	BUY	$278.07 - $446.21 $19.7 Million - $31.7 Million	70,971 Added 48.91%	216,081 $88.4 Million
Q1 2018 May 07, 2018	BUY	$192.49 - $295.85 $1.45 Million - $2.24 Million	7,558 Added 5.49%	145,110 $42.2 Million
Q4 2017 Jan 17, 2018	BUY	$168.78 - $199.74 $1.58 Million - $1.87 Million	9,370 Added 7.31%	137,552 $25.8 Million
Q3 2017 Nov 13, 2017	BUY	$145.39 - $168.6 $18.6 Million - $21.6 Million	128,182	128,182 $21.6 Million

Others Institutions Holding ABMD

# of Institutions

Shares Held

137K

Call Options Held

Put Options Held

View Full List

About ABIOMED INC

Ticker ABMD
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 45,460,900
Description
Abiomed, Inc. engages in the research, development, and sale of medical devices to assist or replace the pumping function of the failing heart. It also provides a continuum of care to heart failure patients. The company offers Impella 2.5, a percutaneous micro heart pump with integrated motor and sensors; and Impella CP, a device for use by inte...

More about ABMD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Charles Schwab Investment Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Charles Schwab Investment Management Inc with notifications on news.

Account